A review of the scientific literature as it pertains to Gulf War illnesses, Depleted uranium.

Contributor(s): Golomb, Beatrice Alexandra | Marshall, Grant N, 1955- | Harley, Naomi H | Spektor, Dalia M | United States. Department of Defense. Office of the Secretary of Defense | National Defense Research Institute (U.S.)
Material type: TextTextSeries: Gulf War illnesses series: v. 7.Publisher: Santa Monica, Calif. : RAND, 1999Description: 1 online resource (144 pages) : illustrations, mapsContent type: text Media type: computer Carrier type: online resourceISBN: 0585344930; 9780585344935; 9780833026811; 083302681XOther title: Depleted uraniumSubject(s): Persian Gulf syndrome | MEDICAL -- Infectious Diseases | HEALTH & FITNESS -- Diseases -- Contagious | Persian Gulf syndrome | Uranium | Radiation Effects | Persian Gulf Syndrome | Metals, Heavy | Occupational Diseases | Radiation | Actinoid Series Elements | Radiologic Health | Metals | Disease | Elements | Electromagnetic Phenomena | Public Health | Elements, Radioactive | Inorganic Chemicals | Physical Phenomena | Environment and Public Health | Phenomena and Processes | Chemicals and Drugs | Delivery of Health Care | Pathology | Medicine | Health & Biological SciencesGenre/Form: Electronic books. | Electronic books. Additional physical formats: Print version:: Review of the scientific literature as it pertains to Gulf War illnesses, Depleted uranium.DDC classification: 616.9/8023 LOC classification: RB152.7 | .R48 1998ebOnline resources: Click here to access online Summary: The confrontation that began when Iraq invaded Kuwait in August 1990 brought with it the threat that chemical and biological weapons might be used against the more than half a million military personnel the United States deployed to the region. To protect these troops from such threats, the Department of Defense wished to use drugs and vaccines that, not having been tested for use in these specific situations, were considered "investigational" by the federal Food and Drug Administration. This report examines the history of the Interim Rule, adopted in December 21, 1990, that authorized the Commissioner of Food and Drugs to waive informed consent for the use of investigational drugs and vaccines for certain military uses; how this authority was used for pyridostigmine bromide and botulinum toxoid during the Gulf War; and the subsequent controversy surrounding the rule, its application, and its implications. -- Provided by publisher.
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
Item type Current location Collection Call number Status Date due Barcode Item holds
eBook eBook e-Library

Electronic Book@IST

EBook Available
Total holds: 0

"Prepared for the Office of the Secretary of Defense, National Defense Research Institute."

"MR-1018-OSD."

Includes bibliographical references.

The confrontation that began when Iraq invaded Kuwait in August 1990 brought with it the threat that chemical and biological weapons might be used against the more than half a million military personnel the United States deployed to the region. To protect these troops from such threats, the Department of Defense wished to use drugs and vaccines that, not having been tested for use in these specific situations, were considered "investigational" by the federal Food and Drug Administration. This report examines the history of the Interim Rule, adopted in December 21, 1990, that authorized the Commissioner of Food and Drugs to waive informed consent for the use of investigational drugs and vaccines for certain military uses; how this authority was used for pyridostigmine bromide and botulinum toxoid during the Gulf War; and the subsequent controversy surrounding the rule, its application, and its implications. -- Provided by publisher.

Print version record.

English.

There are no comments for this item.

to post a comment.

Other editions of this work

A review of the scientific literature as it pertains to Gulf War illnesses. ©1999
Pyridostigmine bromide : by Golomb, Beatrice Alexandra. ©1999
Pyridostigmine bromide : by Golomb, Beatrice Alexandra. ©1999

Powered by Koha